Drugs for Bart-Pumphrey Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 29)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Olaparib |
Approved |
Phase 2 |
|
763113-22-0 |
23725625 |
Synonyms:
4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one
4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one
4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
763113-22-0
937799-91-2
Acylpiperazine analogue, 47
AKOS005145764
AZD 2281
AZD2281
AZD-2281
|
CHEMBL521686
EC-000.2324
EN002690
FT-0083489
KU-0059436
KU-59436
olaparib
Olaparib
Olaparib, KU-0059436, AZD2281, KU0059436, AZD2281
S1060_Selleck
|
|
2 |
|
Bevacizumab |
Approved, Investigational |
Phase 2 |
|
216974-75-3 |
|
Synonyms:
216974-75-3
antiVEGF
Anti-VEGF Humanized Monoclonal Antibody
anti-VEGF monoclonal antibody
Anti-VEGF monoclonal antibody
Avastin
Avastin (TN)
bevacizumab
|
Bevacizumab
Bevacizumab (genetical recombination)
Bevacizumab (genetical recombination) (JAN)
bevacizumab-awwb
D06409
R-435
rhuMAb-VEGF
|
|
3 |
|
Silicon |
Approved, Investigational |
Phase 2 |
|
7440-21-3 |
4082203 |
Synonyms:
|
Silicate
Silicic acid
silicio
|
|
4 |
|
Titanium dioxide |
Approved |
Phase 2 |
|
13463-67-7 |
|
Synonyms:
|
5 |
|
Iron |
Approved |
Phase 2 |
|
7439-89-6 |
23925 29936 |
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
ATW 230
ATW 432
C00023
C3518_SIAL
C3518_SIGMA
Carbonyl iron
CCRIS 1580
CHEBI:18248
CID23925
Copy Powder CS 105-175
D007501
DB01592
Diseases (animal), iron overload
Diseases, iron overload
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Ed-In-Sol
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
Eisen
Electrolytic iron
F 60 (metal)
|
Fe
FE
FE (III) ion
Fe(3+)
Fe(III)
Fe1+
Fe-40
fer
Feronate
Ferretts
Ferric ion
Ferric iron
Ferro-Caps
Ferro-Time
ferrous iron
Ferrousal
Ferrovac E
Ferrum
Ferrum metallicum
FT 3 (element)
GS 6
Hemocyte
HF 2 (element)
hierro
Hierro
HL (iron)
Hoeganaes ATW 230
Hoeganaes EH
HQ (metal)
HS (iron)
HS 4849
HSDB 604
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(3+)
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (fe(3+))
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, reduced
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh1M1
PZh-1M3
PZh-2
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Reduced iron
Remko
Siderol
SUY-B 2
UNII-E1UOL152H7
Vitedyn-Slo
Yieronia
|
|
6 |
|
Mannitol |
Approved, Investigational |
Phase 2 |
|
69-65-8 |
453 6251 |
Synonyms:
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
Ambap69-65-8
AR-1J3861
bmse000099
BRN 1721898
Bronchitol
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
cpd without stereochemical designation
D-(-)-Mannitol
D00062
D008353
Diosmol
DL-Mannitol
D-mannite
D-mannitol
D-Mannitol
D-Mannitol (JP15)
Dulcite
e 421
e421
e-421
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Hexahydroxyhexane
Hexanhexol
HSDB 714
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
|
M9546_SIAL
M9647_SIAL
Manicol
manita
Manitol
Maniton S
Maniton-S
Manna sugar
Manna Sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
mannitol
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol [USAN]
Mannitol 10%
Mannitol 10% In Plastic Container
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
Mannitol 15%
Mannitol 15% In Plastic Container
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
Mannitol 20%
Mannitol 20% In Plastic Container
MANNITOL 25%
Mannitol 5%
Mannitol 5% In Plastic Container
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
Mannitolum
Mannogem 2080
Marine crystal
Marine Crystal
MLS001335977
MLS001335978
MolPort-003-927-039
MTL
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
Osmitrol 15% In Water
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
Osmitrol 20% In Water
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
Osmitrol 5% In Water
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
Sorbitol-Mannitol
SORBITOL-MANNITOL IN PLASTIC CONTAINER
TL806434
Tobrex
UNII-3OWL53L36A
ZINC02041302
|
|
7 |
|
Ferrosoferric Oxide |
|
Phase 2 |
|
|
|
8 |
|
Poly(ADP-ribose) Polymerase Inhibitors |
|
Phase 2 |
|
|
|
9 |
|
Dimenhydrinate |
Approved |
|
|
523-87-5 |
441281 |
Synonyms:
(O-benzhydryl(dimethylamino)ethanol) 8-chlorotheophyllinate
2-(diphenylmethoxy)-N,N-dimethylethanaminium 8-chloro-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-ide
2-benzhydryloxyethyl(dimethyl)azanium
8-chloro-1,3-dimethyl-2-oxopurin-6-olate
8-chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione - 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1)
AC1L9AVV
Benzhydryl-β-dimethylaminoethylether 8-chlorotheophylline
CAS-523-87-5
CHEBI:4604
CID441281
D00520
DB00985
Dimenhidrinato
|
Dimenhydrinate
Dimenhydrinate (JP15/USP/INN)
Dimenhydrinatum
diphenhydramine 8-chlorotheophyllinate
diphenhydramine 8-chlorotheophylline
Diphenhydramine theoclate
Dramamine (TN)
HMS1568F12
N,N-dimethyl-2-diphenylmethoxyethylamine 8-chlorotheophyllinate
NCGC00017026-01
O-benzhydryldimethylaminoethanol 8-chlorotheophyllinate
Prestwick_892
β-dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine
|
|
10 |
|
Colistin |
Approved |
|
|
1066-17-7, 1264-72-8 |
5311054 |
Synonyms:
1066-17-7
AC1NSJWT
CID5311054
Colimycin
Colisticin
colistin
Colistin
Colistin sulfate
Colistin sulfate, nonsterile
Colistin sulphate
Colistina
Colistine
|
Colistinum
Coly-mycin
DB00803
Kolimycin
N-[(1S)-3-Amino-1-{[(1S,2R)-1-{[(1S)-3-amino-1-{[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-2,5,8,11,14,17,20-heptahydroxy-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclotricosa-1,4,7,10,13,16,19-heptaen-21-yl]-C-hydroxycarbonimidoyl}propyl]-C-hydroxycarbonimidoyl}-2-hydroxypropyl]-C-hydroxycarbonimidoyl}propyl]-5-methylheptanimidate
N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide
Polymyxin e
Polymyxin E
Polymyxin E. Sulfate
Sulfate, colistin
Totazina
|
|
11 |
|
Nalidixic Acid |
Approved, Investigational |
|
|
389-08-2 |
4421 |
Synonyms:
1,4-Dihydro-1-ethyl-7-methyl-1,8-naphthyridin-4-one-3-carboxylic acid
1,4-Dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate
1,4-dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
1,4-Dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
1-Aethyl-7-methyl-1,8-naphthyridin-4-on-3-karbonsaeure
1-Aethyl-7-methyl-1,8-naphthyridin-4-on-3-karbonsaeure [German]
1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxilic acid
1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate
1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
1-ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-ca rboxylic acid
1-Ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-carboxylate
1-ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-carboxylic acid
1-Ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-carboxylic acid
1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylate
1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
1-Ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
3374-05-8 (hydrochloride salt, anhydrous)
389-08-2
3-Carboxy-1-ethyl-7-methyl-1,8-naphthidin-4-one
3-carboxy-1-ethyl-7-methyl-1,8-naphthyridin-4-one
3-Carboxy-1-ethyl-7-methyl-1,8-naphthyridin-4-one
5-25-07-00384 (Beilstein Handbook Reference)
AC1L1I4P
AC1Q310A
Acid, nalidixic
Acid, Nalidixic
Acide 1-etil-7-metil-1,8-naftiridin-4-one-3-carbossilico
Acide 1-etil-7-metil-1,8-naftiridin-4-one-3-carbossilico [Italian]
Acide nalidixico
Acide nalidixico [Italian]
Acide nalidixique
Acide nalidixique [French]
Acide nalidixique [INN-French]
Acido nalidissico
Acido nalidissico [DCIT]
Acido nalidixico
Acido nalidixico [INN-Spanish]
Acidum nalidixicum
Acidum nalidixicum [INN-Latin]
AKOS000120074
Anhydrous, nalidixate sodium
BB_NC-2103
Betaxina
BIDD:GT0529
BPBio1_000125
BRD-K47886988-323-03-0
BRN 0750515
BSPBio_000113
BSPBio_001889
C05079
CCRIS 2365
CHEBI:100147
CHEMBL5
CID4421
CPD000058264
Cybis
D00183
D009268
DB00779
DivK1c_000058
Dixiben
Dixinal
EINECS 206-864-7
Eucistin
HMS1921G10
HMS2092K04
HMS500C20
HMS561K17
HSDB 3241
IDI1_000058
InChI=1/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17
Innoxalon
Jicsron
KBio1_000058
KBio2_001398
KBio2_003966
KBio2_006534
KBio3_001109
KBioGR_001333
KBioSS_001398
Kusnarin
Lopac0_000837
LS-72
Maybridge1_007101
MLS000028504
MLS001148578
MLS002303041
MolPort-001-769-233
N0490
N-1200
N5035_SIAL
N8878_SIAL
|
NA
naladixic acid
Naldixic acid
Nalidic acid
Nalidicron
Nalidixan
Nalidixane
Nalidixate
Nalidixate sodium
NALIDIXATE SODIUM
Nalidixate sodium anhydrous
Nalidixic
nalidixic acid
Nalidixic acid
Nalidixic acid (JP15/USP/INN)
Nalidixic acid [USAN:INN:BAN:JAN]
Nalidixic acid USP27
Nalidixin
Nalidixinic acid
Nalidixinsäure
Nalitucsan
Nalix
Nalurin
Narigix
Naxuril
NCGC00018181-01
NCGC00021730-03
NCGC00021730-04
NCGC00021730-05
NCGC00021730-06
NCGC00021730-07
NCI60_041807
NCI-C56199
NCIOpen2_004342
NegGram
NegGram (TN)
Negram
Nevigramon
Nicelate
NINDS_000058
Nogram
NSC82174
NSC-82174
Oprea1_010545
Poleon
Prestwick0_000187
Prestwick1_000187
Prestwick2_000187
Prestwick3_000187
S2328_Selleck
SAM002554914
Sicmylon
SMR000058264
Sodium anhydrous, nalidixate
Sodium nalidixic acid, anhydrous
Sodium Nalidixic Acid, Anhydrous
Sodium nalidixic acid, monohydrate
Sodium Nalidixic Acid, Monohydrate
Sodium, nalidixate
Sodium, Nalidixate
SPBio_001579
SPBio_002034
Specifen
Specifin
Spectrum_000918
SPECTRUM1500756
Spectrum2_001360
Spectrum3_000075
Spectrum4_000817
Spectrum5_001540
SR-01000003086-4
STK735579
Unaserus
UNII-3B91HWA56M
UPCMLD-DP129
UPCMLD-DP129:001
Uralgin
Uriben
Uriclar
Urisal
Urodixin
Uroman
Uroneg
Uronidix
Uropan
VU0239598-6
wil 18,320
WIN 18,320
WIN 183203
WIN-18320
Wintomylon
Wintron
WLN: T66 BN EV JNJ B2 DVQ I1
ZERO/002632
|
|
12 |
|
Chitosan |
Experimental |
|
|
9012-76-4 |
71853 |
Synonyms:
beta-1,4-Poly-delta-glucosamine
beta-1,4-Poly-D-glucosamine
Chicol
Chitopearl 3510
Chitopearl BC 3000
Chitopearl BCW 2500
Chitopearl BCW 3000
Chitopearl BCW 3500
Chitopearl BCW 3505
Chitopearl BCW 3507
Chitosan
Chitosan medium molecular weight (200-800 mpa.s)
CTA 4
Deacetylchitin
|
Flonac C
Flonac N
Kimitsu chitosan F
Kimitsu chitosan F 2
Kimitsu chitosan H
Kimitsu chitosan L
Kimitsu chitosan m
Kytex H
Kytex m
N-[(2S,3R,4R,5S,6R)-5-{[(2S,3R,4R,5S,6R)-3-amino-5-{[(2S,3R,4R,5S,6R)-3-amino-5-{[(2S,3R,4R,5S,6R)-3-amino-5-{[(2S,3R,4R,5S,6R)-3-amino-5-{[(2S,3R,4R,5S,6R)-3-amino-5-{[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-{[(2R,3S,4R,5R,6S)-5-amino-6-{[(2R,3S,4R,5R,6R)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]methoxycarboximidate
Poliglusam
Sea cure F
Sea cure plus
YEA
|
|
13 |
|
3,3'-diindolylmethane |
Investigational |
Early Phase 1 |
|
1968-05-4 |
|
Synonyms:
|
14 |
|
Trichostatin A |
Experimental |
Early Phase 1 |
|
58880-19-6 |
|
Synonyms:
|
15 |
|
Indole-3-carbinol |
Investigational |
Early Phase 1 |
|
700-06-1 |
3712 |
Synonyms:
(1H-indol-3-yl)Methanol
1H-indol-3-Ylmethanol
1H-Indole-3-methanol
3-(Hydroxymethyl)indole
3-Hydroxymethylindole
3-Indolecarbinol
|
3-Indolylcarbinol
3-Indolylmethanol
I3c CPD
Indinol
Indole-3-carbinol
Indole-3-methanol
|
|
16 |
|
Indole |
Experimental |
Early Phase 1 |
|
120-72-9 |
798 |
Synonyms:
1-Azaindene
1-Benzazole
2,3-Benzopyrrole
Benzo[b]pyrrole
|
|
|
17 |
|
Vaccines |
|
|
|
|
|
18 |
|
Anti-Infective Agents |
|
|
|
|
|
19 |
|
Hemostatics |
|
|
|
|
|
20 |
|
Anti-Bacterial Agents |
|
|
|
|
|
21 |
|
Histamine Antagonists |
|
|
|
|
|
22 |
|
Antimetabolites |
|
|
|
|
|
23 |
|
Hypolipidemic Agents |
|
|
|
|
|
24 |
|
Lipid Regulating Agents |
|
|
|
|
|
25 |
|
Histamine H1 Antagonists |
|
|
|
|
|
26 |
|
Coagulants |
|
|
|
|
|
27 |
|
Anticholesteremic Agents |
|
|
|
|
|
28 |
|
Chelating Agents |
|
|
|
|
|
29 |
|
Emollients |
|
|
|
|
|
Interventional clinical trials:
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Phase II Study of Olaparib in Metastatic Renal Cell Carcinoma Patients Harboring a BAP-1 or Other DNA Repair Gene Mutations (ORCHID) |
Recruiting |
NCT03786796 |
Phase 2 |
Olaparib |
2 |
Chiropractors Can Do: Testing the Feasibility of Intervening to Optimize Chiropractic Care for Adults With Neck Pain Disorders: A Pilot Cluster Randomized Controlled Trial |
Completed |
NCT02483091 |
Phase 1 |
|
3 |
Measurement and Comparison of the Occlusive and Hydrating Capacity of Three Silicone Gels: BAP Scar Gel, Dermatix, Kelocote and One Gel- Cream: Alhydran |
Completed |
NCT01413789 |
|
Dermatix;Kelocote;BAP scar gel;Alhydran;Bap Scar Care T;Bap Scar Care S;Mepiform;Scar Ban Elastic |
4 |
The Use of Expanded Quantitative Urinary Culture (EQUC) Versus Standard Culture (SUC) Techniques in the Clinical Care of Women With Symptoms of Urinary Tract Infections. |
Completed |
NCT03190421 |
|
|
5 |
Pragmatic Randomized Controlled Multi Center Trial Comparing the Effectiveness of Antibacterial Therapeutic Clothing Based on Silver or Chitosan as Compared With Non-antibacterial Therapeutic Clothing in Patients With Moderate to Severe Atopic Dermatitis |
Recruiting |
NCT04297215 |
|
|
6 |
Human Embryonic Stem Cell-derived Trophoblastic Spheroid (BAP-EB) as a Predictive Tool for Endometrial Receptivity and Pregnancy Outcome of in Vitro Fertilization Treatment |
Recruiting |
NCT02713854 |
|
|
7 |
Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet |
Active, not recruiting |
NCT03802721 |
Early Phase 1 |
[14C]-benzo[a]pyrene;Brussels sprouts before 50 ng dose;DIM supplement before 50 ng dose |
|